boswellic acid has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Guo, C; Li, W; Wang, J; Wang, M; Weng, Y; Yang, Q; Yu, J; Zhang, W | 1 |
| Aghamiri, SH; Aghamollaii, V; Alborzi, AT; Baram, SM; Fotouhi, A; Gharahje, S; Hosseinizadeh, M; Kabiri, S; Karima, S; Lima, BS; Mahdavi, M; Mansouri, B; Rajaei, S; Shahamati, SZ; Shateri, S; Tafakhori, A; Tehrani, HS | 1 |
1 trial(s) available for boswellic acid and Brain Ischemia
| Article | Year |
|---|---|
Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chemokines; Cytokines; Dinoprost; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Stroke; Triterpenes | 2019 |
1 other study(ies) available for boswellic acid and Brain Ischemia
| Article | Year |
|---|---|
Beta-Boswellic Acid Protects Against Cerebral Ischemia/Reperfusion Injury via the Protein Kinase C Epsilon/Nuclear Factor Erythroid 2-like 2/Heme Oxygenase-1 Pathway.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Ischemic Stroke; Neuroprotective Agents; NF-E2-Related Factor 2; Protein Kinase C-epsilon; Rats; Reperfusion Injury; Signal Transduction; Triterpenes | 2022 |